Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized open-label trial of bendamustine vs chlorambucil in untreated Binet B/C B-CLL
2004-000860-28Phase 3Completed
- Sponsor
- Ribosepharm
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bendamustine in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and anaemia (2 arms), sponsored by Ribosepharm. Primary endpoints: Overall remission rate (CR + PR) and Progression-free survival. Started Oct 2004; status: completed.
02
Drugs
bendamustine
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)anaemia
Beyond the preview
Go deeper on 2004-000860-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000860-28.